List of SBIR/STTR awards granted to Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc.Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Acorda Therapeutics, Inc. for $156,491.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS052921-01 | Phase I | 156,491 | ||||||||
A SBIR Phase I contract was awarded to Acorda Therapeutics, Inc. for $184,388.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS051863-01 | Phase I | 184,388 | ||||||||
A STTR Phase II contract was awarded to Acorda Therapeutics, Inc. for $980,125.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42NS040172-02 | Phase II | 980,125 | ||||||||
A SBIR Phase I contract was awarded to Acorda Therapeutics, Inc. for $107,300.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS046821-01 | Phase I | 107,300 | ||||||||
A SBIR Phase I contract was awarded to Acorda Therapeutics, Inc. for $153,151.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS050894-01A1 | Phase I | 153,151 | ||||||||
A STTR Phase I contract was awarded to Acorda Therapeutics, Inc. from the U.S. Department of Health & Human Services. | STTR | 2R42NS040172-02 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to Acorda Therapeutics, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 100,000 | |||||||||
A SBIR Phase I contract was awarded to Acorda Therapeutics, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 100,000 | |||||||||
A STTR Phase I contract was awarded to Acorda Therapeutics, Inc. for $195,526.0 USD from the U.S. Department of Health & Human Services. | STTR | Phase I | 195,526 | |||||||||
A SBIR Phase I contract was awarded to Acorda Therapeutics, Inc. for $139,371.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 139,371 |
